TP53 and cancer: As senescence leads to cell cycle arrest, at least in part, this process is linked to cancer suppression, being regulated by two major pathways: the p53/p21; and the cyclin-dependent kinase inhibitor 2A and Retinoblastoma-associated protein (p16INK1a/pRB), which are considered senescence markers [362].